MEJIIXTY

Serial Number 97236795
733

Registration Progress

Application Filed
Jan 25, 2022
Under Examination
Aug 8, 2023
Approved for Publication
Jun 13, 2023
Published for Opposition
Jun 13, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 4 Granted
Due: Feb 08, 2026 95 days

Trademark Image

MEJIIXTY

Basic Information

Serial Number
97236795
Filing Date
January 25, 2022
Published for Opposition
June 13, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Aug 7, 2025
Application
Pending
Classes
005

Rights Holder

Aspargo Laboratories, Inc.

03
Address
550 Sylvan Avenue, Suite 102
Englewood Cliffs, NJ 07632

Ownership History

Aspargo Laboratories, Inc.

Original Applicant
03
Englewood Cliffs, NJ

Aspargo Laboratories, Inc.

Owner at Publication
03
Englewood Cliffs, NJ

Legal Representation

Attorney
Anthony E. Bennett

USPTO Deadlines

Next Deadline
95 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
February 08, 2026
Extension Available
Until August 08, 2024

Application History

30 events
Date Code Type Description Documents
Aug 8, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 7, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 7, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 7, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 8, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 8, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 7, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 7, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 2, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 2, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 2, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 2, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 9, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 7, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 7, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 7, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 8, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 13, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 13, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 24, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 8, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 4, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 4, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 4, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 4, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 4, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 4, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 3, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 28, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 28, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical compounds, namely, pharmaceutical preparations for the treatment of erectile dysfunction and for the treatment of hypertension; pharmaceutical preparations, namely, sildenafil for the treatment of erectile dysfunction and for the treatment of hypertension; pharmaceutical preparations in the nature of an oral spray formulation of sildenafil for the treatment of erectile dysfunction and for the treatment of hypertension; a drug delivery device prefilled with pharmaceutical products for the treatment of erectile dysfunction and for the treatment of hypertension

Classification

International Classes
005